Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk neuroblastoma [Yahoo! Finance]
AGC INC UNSP/ADR (ASGLY)
NASDAQ:AMEX Investor Relations:
newsquantified.com/asgly/sec-filings-report/agc-american-depositary-receipts-unsponsored-form-f6-incadr-filed-bank-05ks9e
Company Research
Source: Yahoo! Finance
Egham, UK and Copenhagen, Denmark – 11 June, 2024 – Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically differentiated, niche pharmaceutical products across key therapeutic areas, today announced its rare disease business has signed a strategic agreement with AGC Biologics . As a leading global biopharmaceutical contract development and manufacturing organisation (CDMO), AGC Biologics will produce Hu1418K322A (Hu14.18), a humanised monoclonal antibody being developed for Essential Pharma for the treatment of high-risk neuroblastoma (HRNB). Under the agreement, AGC Biologics will support the process development, scale-up and manufacturing as Essential Pharma plans to commence clinical activities and ongoing regulatory agency interactions over the coming months. Simon Ball, Vice President of the rare disease business at Essential Pharma, commented : "This partnership is a tremendous milestone
Show less
Read more
Impact Snapshot
Event Time:
ASGLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASGLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASGLY alerts
High impacting AGC INC UNSP/ADR news events
Weekly update
A roundup of the hottest topics
ASGLY
News
- Mesoporous Silica Market to Grow at CAGR of 10% through 2033 - Rising Potential Applications in Pharmaceuticals & Healthcare Sector to Propel Growth [Yahoo! Finance]Yahoo! Finance
- AGC Biologics & Chief Executive Officer Patricio Massera Announce Plans for Him to Step Down [Yahoo! Finance]Yahoo! Finance
- AGC Biologics Completes Copenhagen Campus Expansion, Doubling Single-use Mammalian Bioreactor Capacity at Site [Yahoo! Finance]Yahoo! Finance
- AGC Biologics and BioConnection Partner to Offer new End-to-End Biopharmaceutical Drug Substance and Drug Product Development and Manufacturing Offering [Yahoo! Finance]Yahoo! Finance
- Scratch-Resistant Glass Market Size to Worth $22.2 Billion by 2032 | CAGR: 11.4%: AMR [Yahoo! Finance]Yahoo! Finance